Liwei Wang
Impact in
- Oncology top 1%
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Cytokine Signaling Pathways and Interactions
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Oncology 63
- Pancreatic and Hepatic Oncology Research 20
- Cancer Immunotherapy and Biomarkers 11
- Colorectal Cancer Treatments and Studies 11
- CAR-T cell therapy research 6
-
- Epigenetics and DNA Methylation 8
- Kruppel-like factors research 6
- Co-authors
- Keping Xie (10 shared papers)Daoyan Wei (7 shared papers)Xiangdong Le (7 shared papers)Suyun Huang (6 shared papers)Weihua Jiang (6 shared papers)Jiao Feng (11 shared papers)Jiujie Cui (13 shared papers)Hai Hu (9 shared papers)
- Journals
- Journal of Clinical Oncology (16 papers)Oncotarget (7 papers)Cancer Research (5 papers)Scientific Reports (3 papers)Tumor Biology (3 papers)
- Partner nations
- ChinaUnited StatesSpain
In The Last Decade
Liwei Wang
108 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Oncology 2.0k
- Cancer Research 825
- Molecular Biology 1.9k
- Pathology and Forensic Medicine 494
- Pulmonary and Respiratory Medicine 778
Countries citing papers authored by Liwei Wang
This map shows the geographic impact of Liwei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liwei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liwei Wang more than expected).
Fields of papers citing papers by Liwei Wang
This network shows the impact of papers produced by Liwei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liwei Wang. The network helps show where Liwei Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Liwei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 112 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2015 | 553 |
| 2 | 2003 | 464 | |
| 3 | 2014 | 184 | |
| 4 | 2011 | 147 | |
| 5 | 2016 | 140 | |
| 6 | 2009 | 129 | |
| 7 | Prognostic value of CRM1 in pancreas cancer. | 2009 | 124 |
| 8 | 2005 | 122 | |
| 9 | 2012 | 121 | |
| 10 | 2013 | 86 | |
| 11 | 2015 | 86 | |
| 12 | 2011 | 85 | |
| 13 | 2016 | 74 | |
| 14 | 2016 | 72 | |
| 15 | 2010 | 68 | |
| 16 | 2017 | 67 | |
| 17 | 2010 | 63 | |
| 18 | 2004 | 57 | |
| 19 | 2015 | 56 | |
| 20 | 2010 | 53 |
About Liwei Wang
Liwei Wang is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Surgery, having authored 112 papers that have together received 3.9k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (20 papers), Cancer Immunotherapy and Biomarkers (11 papers), Gastric Cancer Management and Outcomes (11 papers), Colorectal Cancer Treatments and Studies (11 papers), Epigenetics and DNA Methylation (8 papers), Cancer, Lipids, and Metabolism (6 papers), Kruppel-like factors research (6 papers) and CAR-T cell therapy research (6 papers). The work is most often cited by research in Oncology (2.0k citations), Cancer Research (825 citations), Molecular Biology (1.9k citations), Pathology and Forensic Medicine (494 citations) and Pulmonary and Respiratory Medicine (778 citations). Liwei Wang has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Keping Xie, Daoyan Wei, Xiangdong Le, Suyun Huang, Weihua Jiang, Jiao Feng, Jiujie Cui, Hai Hu, Weiyi Huang and Ziliang Jin. Their work appears in journals such as Journal of Clinical Oncology, Oncotarget, Cancer Research, Scientific Reports and Tumor Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.